8-K ·Filed Mar 13, 2026

INDV

Indivior Pharmaceuticals, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001625297-26-000012
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor for supplemental filing or press release that clarifies the nature of the event disclosed under Item 8.01. Absent content, assume no immediate trading impact.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
INDV ▲ +20.19% at T+60d
NEUTRAL call ✓ call won +20.19% · α vs SPY +8.57% · entry $31.11 → $37.39
Entry anchored
Mar 12, 03:59 PM ET
via exchange tick
T+1d
-0.45%
call -0.45% · α -1.47%
$30.97
settled 7mo ago
T+5d
-5.82%
call -5.82% · α -3.70%
$29.30
settled 7mo ago
T+20d
+1.58%
call +1.58% · α -2.01%
$31.60
settled 6mo ago
T+60d
+20.19%
call +20.19% · α +8.57%
$37.39
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. The 8-K filing includes Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), which may indicate a corporate announcement or disclosure of material events, but no specific details can be confirmed without the full filing. Insider buying activity has been minimal recently.

Key Facts

  • Filing is an 8-K with Items 8.01 and 9.01 reported
  • No document content available to assess the nature of the event or exhibits
  • Item 8.01 typically covers material corporate events such as litigation, regulatory actions, or press releases
  • Item 9.01 indicates inclusion of financial statements or material agreements as exhibits
  • Recent insider activity shows 2 small buys totaling $31K

Financial Impact

Not specified

Risk Factors

  • Material adverse event possible if litigation or regulatory action is involved
  • Risk of delayed disclosure if exhibit is not yet filed

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

Report based on filing metadata.

18 reports for INDV
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +21.73%Apr 24, 2026
Filters
Rows
Reports for INDV — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
EFFECT
NEUTRAL ★ 4/10
$34.47 $35.53▲ +3.08%▲ +2.97%$35.71 (+3.60%)
Aug 28, 2026
4w ago
S-4
NEUTRAL ★ 6/10
$34.93 $34.32▼ −1.75%▼ −1.60%$35.71 (+2.23%)
Aug 3, 2026
8w ago
425 / 8-K
BULLISH ★ 8/10
$37.37 $38.47▲ +2.94%▲ +0.92%$35.71 (−4.44%)
Aug 3, 2026
8w ago
425
BULLISH ★ 8/10
$37.37 $38.47▲ +2.94%▲ +0.92%$35.71 (−4.44%)
Aug 3, 2026
8w ago
8-K
BULLISH ★ 8/10
$37.37 $38.47▲ +2.94%▲ +0.92%$35.71 (−4.44%)
Aug 3, 2026
8w ago
425 / 8-K
BULLISH ★ 7/10
$37.37 $38.47▲ +2.94%▲ +0.92%$35.71 (−4.44%)
Jul 23, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$40.51 $40.22▼ −0.72%▼ −1.19%$35.71 (−11.85%)
Jun 12, 2026
16w ago
Insider Cluster
NEUTRAL ★ 4/10
$38.40 $38.32▼ −0.21%▲ +1.17%$35.71 (−7.01%)
May 15, 2026
20w ago
8-K
NEUTRAL ★ 3/10
$36.54 $37.81▲ +3.48%▲ +1.86%$35.71 (−2.27%)
May 4, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$38.98 $38.84▼ −0.36%▼ −3.30%$35.71 (−8.39%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (64h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access